Findings from the Adjuvant Colon Cancer End Points (ACCENT) Collaborative Group: the power of pooled individual patient data from multiple clinical trials.
- Citation:
- Chin Clin Oncol vol 5 (6) 80
- Year:
- 2016
- Type:
- Manuscript
- Funding:
- Not Funded
- Endpoint:
- Secondary-not-in-original
- Analysis:
- Primary
- Data Sharing:
- No-Data-Sharing
- Status:
- Presented/Published
- Citation Status:
- ppub
- Note:
- Methodological:
- No
- Biospecimen:
- No
- SDC:
- Yes
- Book Volume:
- Parents:
- None
- Children:
- None
- Pharmas:
- Grants:
- Corr. Author:
- Authors:
- Lindsay A Renfro Daniel J Sargent
- Networks:
- Study
- NCCTG-N0441
- Multiple Studies, or Legacy Studies in Alliance Study:
- Phases:
- Keywords:
- Adjuvant Colon Cancer End Points (ACCENT), FOLFOX, adjuvant treatment, colon cancer, disease-free survival (DFS), individual patient data, meta-analysis, overall survival (OS), oxaliplatin, population survival, recurrence, surrogate endpoints